TickerLeague

Buyback Spend for AstraZeneca (AZN)

Buyback Spend for AstraZeneca (AZN): headline value $211.58M. Annual and quarterly series, chart, and tables are below.

Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .

Latest period

$211.58M

YoY change

N/A

5Y CAGR

N/A

Peak year (2011)

$6.01B

Latest annual

$719.66M

Buyback Spend history chart for AstraZeneca (AZN) from 1990 to 2025

Buyback Spend history table for AstraZeneca (AZN) from 1990 to 2025

Fiscal yearPeriod endedReportedBuyback SpendYoY
2025$719.66M
2024$0
2023$0
2022$0
2021$0
2020$0
2019$0
2018$0
2017$0
2016$0
2015$0
2014$0
2013$0-100.0%
2012$2.63B-56.2%
2011$6.01B+131.0%
2010$2.60B
2009$0-100.0%
2008$610.00M-85.4%
2007$4.17B+0.6%
2006$4.15B+38.2%
2005$3.00B+35.7%
2004$2.21B+99.8%
2003$1.11B-4.1%
2002$1.15B+6.9%
2001$1.08B+205.1%
2000$353.98M+93.4%
1999$183.00M
1998$0
1997$0
1996$0
1995$0
1994$0
1993$0
1992$0
1991$0
1990$0

Buyback Spend values are taken from AstraZeneca's reported cash flow statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.

Analysis

2025's annual buyback spend for AstraZeneca (AZN) came in at $719.66M.

Between 2011 and 2025, AstraZeneca buyback spend plunged 88.0%, falling from $6.01B to $719.66M.

The highest annual buyback spend of $6.01B was reported in 2011. The lowest in the available history was $0 in 1990.

Among 8 Healthcare peers, AstraZeneca (AZN) ranks 8th; the peer median for buyback spend is $3.55B.

AstraZeneca Buyback Spend by Year

AstraZeneca Buyback Spend 2025: $719.66M

AstraZeneca buyback spend in 2025 was $719.66M.

AstraZeneca Buyback Spend 2024: $0

AstraZeneca buyback spend in 2024 was $0.

AstraZeneca Buyback Spend 2023: $0

AstraZeneca buyback spend in 2023 was $0.

AstraZeneca Buyback Spend 2022: $0

AstraZeneca buyback spend in 2022 was $0.

AstraZeneca Buyback Spend 2021: $0

AstraZeneca buyback spend in 2021 was $0.

See more financial history for AstraZeneca (AZN).

Sector peers — Buyback Spend

Companies in the same sector as AstraZeneca, ranked by their latest buyback spend.

CompanyBuyback SpendSector
Johnson & Johnson (JNJ)$5.95BHealthcare
UnitedHealth Group Incorporated (UNH)$5.54BHealthcare
Merck & Co., Inc. (MRK)$5.08BHealthcare
Eli Lilly and Company (LLY)$4.11BHealthcare
Thermo Fisher Scientific Inc. (TMO)$3.00BHealthcare
Novo Nordisk A/S (NVO)$1.39BHealthcare
AbbVie Inc. (ABBV)$980.00MHealthcare
Amgen Inc. (AMGN)$0Healthcare

Frequently asked questions

What is AstraZeneca's buyback spend?

Latest reported buyback spend for AstraZeneca (AZN) is $211.58M (period ending December 31, 2025).

When did AstraZeneca buyback spend hit its highest annual value?

AstraZeneca buyback spend reached its highest annual value of $6.01B in 2011.

What was AstraZeneca buyback spend in 2024?

AstraZeneca (AZN) buyback spend in 2024 was $0.

What was AstraZeneca buyback spend in 2025?

AstraZeneca (AZN) buyback spend in 2025 was $719.66M.

Metrics overview

Pick a metric for charts, filings and peers — each row shows the latest TTM or most-recent-quarter value.